MedTrace Logo

Prevalence of Childhood Maltreatment Among Women With Dysmenorrhea.

NCT07786688 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2026-08-26

No results posted yet for this study

Summary

Dysmenorrhea is defined by the French National College of Gynecologists and Obstetricians as "cyclic abdominopelvic pain, occurring around menstruation, beginning shortly before its onset and sometimes persisting afterward." Its prevalence is difficult to determine precisely, but studies show that 16 to 90% of women in the general population experience permanent or occasional dysmenorrhea, and that more than 20% of them must limit their activities during menstruation. The origins of this pain remain poorly understood, but it is now known to be associated with significant emotional, psychological, and functional health consequences. Several studies have demonstrated that a history of violence experienced during childhood and adolescence is associated with the onset of chronic pain, but to the investigators' knowledge, no study has specifically analyzed the impact of violence on the presence of dysmenorrhea in adulthood. This study aims to administer a questionnaire assessing dysmenorrhea and history of violence (Childhood Trauma Questionnaire, short French version - CTQ) to patients consulting the Gynecology Department of Estaing University Hospital for menstrual pain (dysmenorrhea). The investigators aim to identify an association between the presence of dysmenorrhea and a history of violence during childhood.

Conditions

  • Dysmenorrhea

Interventions

DIAGNOSTIC_TEST

CTQ short version

We propose a medical appointment to all the women with a positive score at the CTQ short version

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
53 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-25
Primary Completion
2027-10-01
Completion
2027-10-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07786688 on ClinicalTrials.gov